American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus
Since the discovery of insulin, many sophisticated tools have been developed to help people with diabetes maintaining a healthy lifestyle. George Grunberger and colleagues conducted a study under the title “American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus” published in American Association of Clinical Endocrinology (AACE) Clinical Practice Guideline. The summary of this article is given below:
Objective:
To suggest evidence-based recommendations for using the advanced technology in the management of persons with diabetes mellitus to clinicians, health care professionals,diabetes-care teams, and other stakeholders.
Method:
A literature search was conducted by the AACE for relevant articles published between 2012 to 2021. A team of medical experts developed evidence-based guideline recommendations in accordance with the review of clinical evidence, informal consensus, and expertise, and based on the established AACE protocol for guideline development.
Finding:
While advanced diabetes technology promises to make beneficial effects on living for people with diabetes, it is not the solution in its current state. Providing universal access to these technologies is important in order to help more people in improving glycemia, quality of life, reduce the complexity of the condition. Refinement in available technology such as reduction in size, including real-time data availability system is anticipated. The call to action at present is to ensure adequate payer coverage, education of patients with diabetes on available devices, and guidance for including these tools into the care regimen.
As there is rapid advancement in the field of diabetes, clinicians and other healthcare teams should work alongside these developments.
Limitation:
Due to the rapid development cycle, there was the unavailability of comparative data in each category to all available devices. There are limited studies that are well-designed to assess the effectiveness and clinical target. On the other side, many studies with small
sample sizes, short duration, and homogeneous populations were available.
Image Credit : Background photo created by xb100 – www.freepik.com